SlideShare a Scribd company logo
Nuclear
Cardiology
Frank Meissner, MD, FACP, FACC, FACP
Chief of Cardiology
General Appoach
●IV administration of radiolabeled
agents
●Scintillation or positron camera
●Computer processing
●Physiologic/functional data, rather
than structural/anatomic
●e.g., Myocardial perfusion imaging is
prognostically more important than
classification by angiography
Types of Studies/Agents
●Myocardial Perfusion Thallium-201
(201Tl), technetium-99m sestamibi
●Blood Pool/First Pass Tc 99m
pertechnetate
●Myocardial Infarct
●PET
Myocardial Perfusion
-Thallium 201 imaging
●Intracellular transport by passive and
active mechanisms
●Early myocardial uptake directly
proportional to regional myocardial
blood flow and myocardial extraction
fraction
Myocardial Perfusion
-Thallium 201 imaging
●After initial phase continuous
exchange of myocardial 201Tl and
extracardiac 201Tl
●This process of continuous
exchange is the basis of 201Tl
redistribution
●Thallium, metallic element group IIIA
- periodic table
Thallium Redistribution
●Defined as total or partial resolution
of initial postexercise defects
●Reimaging at 2.5 to 4 hrs after tracer
injection
●Late reimaging is performed when
defects are believed to be due to
severe ischemia
Technical Considerations
●2.5 to 3.0 mCi of 201Tl via IV cannula
●End-points: angina , dyspnea,
fatigue, claudication, hypotension
●Exercise 30 to 45 s so that initial
myocardial uptake reflects peak
exercise
●Image within 5 minutes post exercise
Thallium TMT interpretation
●Decreased 201Tl uptake ischemia or
scar
●Reversible defects = ischemia
●30% of persistent defects = severe
ischemia rather than scar
●Reinjection protocols reveals
reversibility in 40% of 4 hr ‘defects’
●24 hr redistribution imaging show
reversibility in 20-25% of ‘fixed’ 4
Sensitivity/Specificity
Considerations
●Qualitative visual 201Tl using planar
imaging sensitivity and sensitivity of
84 & 87% respectively
●Quantatively analysis (computer
assistance) 90% sensitivity &
specificity
●Spect 201 Tl increased sensitivity
with decreased specificity
SPECT ADVANTAGES
●Images free of background
●Lesion contrast higher
●Localization of defects is more
precise and more clearly seen by the
inexperienced eye
●Extent and size of defects better
defined
Sensitivity Factors
●Left circumflex lesions difficult to ID
●Branch stenoses of arteries more difficult
●Sensitivity for single vessel disease <<
sensitivity for multivessel disease
●Less sensitive suboptimal exercise
●Not influcenced by antianginal drugs
●NOT a good test post-CABG
HIGH RISK Characteristics
●Multiple 201 Tl defects in multiple
vascular regions
●Increased Lung uptake (defined by
lung/heart ratio > .5)
●Exercise induced transient LV
dilatation
PROGNOSTIC
Characteristics
●Presence of reversible defects worse
prognosis than fixed defects
●Total number of defects best
prognositic indicator vs Presence of
Lung uptake (reported as POORER
prognosis than total segments)
●Chest Pain + TOTALLY normal 201Tl
scans < 1% yrly risk of sudden death
Resting Thallium
●Useful technique for case selection in
patients with depressed LVEF & CAD
●‘Hibernating’ myocardium preserved
201Tl uptake at rest
●IV 201Tl imaged at 20 mins and 4 hours
●Resting hypoperfusion will demonstrate
initial defects that fill with redistribution
●Asynergy with preserved 201Tl uptake
improved systolic function post-Bypass
201Tl Limitations
●Breast tissue attenuates tracer
penetration
●Large RV blood pool overlying inferior
wall on Anterior Projection => artifact
●High left Hemidiaphragm overlying post
wall
●SPECT imaging relatively less than 201Tl
activity in the inferobasilar segments on
short axis images
99mTc sestamibi Imaging I
●Lipophilic cationic 99mTc-complex
whose myocardial uptake
proportional to blood flow
●140 keV photon energy peak is
optimized for gamma camera
imaging
●Produces higher quality images than
those produced by 201Tl
99mTc sestamibi Imaging II
●Shorter half life than 201Tl permits
administration of 10-15 X’s as high a
dose of tracer than 201Tl
●Gated acquisition of SPECT allows for
animation and rgn wall motion
analysis
●First PASS acquisition can yield LVEF
at rest or exercise with animation for
MUGA like scans done prior to
99mTc-sestamibi Technical
Characteristics
●Does NOT redistribute after injection
●Separate injections during stress and resting
states
●Ideal protocol is 24 hours between rest and
stress
●However, current practice is to inject and
image rest followed by Stress images
●Increased photon energy defeats attenuation
& artifacts
Sensitivity & Specificity
●Sensitivity is reported at 85-90%
range
●Increased specificity with superior
image quality and decreased image
artifacts
●Some authors report more
individually stenosed arteries are
dected by sestabmibi SPECT than
Pharmacologic Stress
Imaging
●Useful for patients UNABLE to exercise to
reasonable double products
●Adenosine vs dipyridamole protocols
●Critical coronary stenosis detected by
reduced flow reserve in stenotic area
●Degree of vasodilatation is less relative to
increase in flow in normal segments
●Sensitivity and specificity is comparable to
that reported with exercise protocols
Dipyridamole Stress
Imaging: Cavets/Technique
●NO caffeinated beverages for 12 hrs prior to
the test
●NO use of Theophylline compounds
●0.56 mg/kg dipyridamole infused over 4
minutes
●3.0 mCi 201Tl injected at 9 minutes, with
intial images at 5 mins post injection
●Aminophylline (50-100 mg IV) for systemic
hypertension, chest pain, severe nausea
Adenosine Stress Imaging:
Technique
●IV adenosine 140ug/kg/min for 6
minutes
●3 mins after starting infusion inject
with 3.0 mCi dose of 201Tl in
contralateral vein
●Additional 3 minute infusion of
adenosine
USEFULNESS of
Pharmacological stress
testing
●Predominately for PreOp eval of
vascular surgical patient
●Preoperative 201Tl defects
experience a 7X > periorperative
ischemic event rate
●PATIENTS WITH RECURRENT
ANGINA AT REST should NOT
receive pharmacological stress
Radionuclide angiography
●Blood pool imaging rather than
myocardial avid tracers
●Information obtained is identical to
that of contrast ventriculography
●In vivo labeling with 99mTc
●IV stannous pyrophosphate is
injected 15-20 mins prior to 15-30
mCi of 99mTc
Uses I
●Differentiation of ischemic from
nonischemic cardiomyopathy
●Cancer patient monitoring for
doxorubicin by serial estimate of EF
●RV fxn and size with first pass for
suspected RV infarction
●RV dynamics in COPD
Uses II
●Bicycle ergometry for detection of
CAD
●Timing of valve replacement in
regurgitant valvular disease - serial
studies
●Post MI risk stratification
First Pass Imaging
●Single bolus of 99mTc is injected rapidly via
IV (preferably central line)
●Analysis is limited to intial transit
Multicrystal scintillation camera prefered to
single-crystal Anger Camera, since high
count
●Rates (up to 400,000 counts/sec) can be
obtained with multiple crystal cameras
Equilibration Imaging I
●Multiple Gated Acquisition Scan (MUGA)
●Equal subdivisions of the patients
cardiac cycle
●Generally 30-50ms framing interval at
rest or 20-30 ms for exercise study
●200 successive cardiac cycles, with
R-wave gating
Equilibration Imaging II
●Several algorithms and methods to
deal with R-R wave variability
●DO NOT SEND A Fib or
Bigemy/Trigemeny patient to MUGA
●Time Activity Curve - Relative volume
curve
●Displayed with activity in LV vs time
●Change in activity is proportional to
change in LV volume
Data Obtained
●LVEF
●RVEF
●Peak systolic ejection rate
●Regurgitant fraction
●Diastolic filling time
●Left to right intracardiac shunts
●Phase analysis
MUGA Advantages
●Highly reproducible EF
●Able to image patients NOT well seen
with Echo
●NO geometric assumptions are made
in the calculation of EF (MOST
IMPORTANT ADVANTAGE)
●Wall motion analysis is VERY
comparable to ECHO & LV-gram
Myocardial infarction
imaging
●Radiopharmaceutical is preferentially
sequestered in necrotic myocardial tissue
●Yields a hot spot on the scan
●99mTc pyrophosphate first agent used
●Scan is abnormal 12-24 hours after MI
●Recent interest in indium-111(111In)
antimyosin antibodies
Technique
●Fab fragments of antimyosin
antibodies labeled with 111In
●Images obtained one hour after
injection
Clinical Uses
●NOT useful for routine patients
●Late patients (>2 days from Chest
pain with negative enzymes and
equivocal EKG’s)
●Surgical MI’s, i.e., patient felt to have
MI in OR
●Acute Myocarditis
●Acute and chronic allograft rejection
PET
●Positron emission tomography
●Imaged with short half life positron
emitors such as carbon-11 (11C),
nitrogen-13 (13N), oxygen-15 (15O),
fluorine-18 (18F), and rubidium-82
(82Rb)
●Generator produced half lifes of 75
seconds to 2 minutes
Uses
●Research TOOL ONLY
●For testing purposes the hallmark of
Myocardial Viability in ‘stunned’ or
hibernating myocardium is increased FDG
(18F, 2-fluoro-2-deoxyglucose) activity in
myocardial tissue
●Diminished perfusion with increased FDG
activity is due to glycolysis
●Diminished perfusion with diminished FDG
activity implies NO viability
THE
END

More Related Content

What's hot

Early reperfusion in myocardial infarction
Early reperfusion in myocardial infarctionEarly reperfusion in myocardial infarction
Early reperfusion in myocardial infarction
cardiositeindia
 
Nuclear cardiology
Nuclear cardiologyNuclear cardiology
Nuclear cardiology
SGPGI, lucknow
 
Anaesthesia for orthopaedic replacement surgeries
Anaesthesia for orthopaedic replacement surgeriesAnaesthesia for orthopaedic replacement surgeries
Anaesthesia for orthopaedic replacement surgeries
Dhritiman Chakrabarti
 
Seizures post cardiac surgery
Seizures post cardiac surgerySeizures post cardiac surgery
Seizures post cardiac surgery
Kunwar Saurabh
 
Myocardial viability
Myocardial viabilityMyocardial viability
Myocardial viability
Raghuram Krishnan
 
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
Hafeesh Fazulu
 
Management of no reflow
Management of no reflowManagement of no reflow
A case of prosthetic mitral valve with
A case of prosthetic mitral valve  withA case of prosthetic mitral valve  with
A case of prosthetic mitral valve with
Abhijeet Patil
 
STEMI – My Approach 2010
STEMI – My Approach 2010STEMI – My Approach 2010
STEMI – My Approach 2010
ishakansari
 
Poster 33 biochimie
Poster 33 biochimiePoster 33 biochimie
Poster 33 biochimie
JIB Congress
 
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, AlternativesAnesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
NC Association of Nurse Anesthetists
 
Perioperative management of antithrombotic therapy
Perioperative management of antithrombotic therapyPerioperative management of antithrombotic therapy
Perioperative management of antithrombotic therapy
Zaito Hjimae
 
Percutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarctionPercutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarction
Ramachandra Barik
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRI
NAJEEB ULLAH SOFI
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua
Hiralal Pawar
 
Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (
Natalia Perez de Arriba
 
Anesthesia in patients on anti coagulants
Anesthesia in patients on anti coagulantsAnesthesia in patients on anti coagulants
Anesthesia in patients on anti coagulants
Navin Jain‬
 
high blood pressure 19
high blood pressure 19high blood pressure 19
high blood pressure 19
discreetfuton2773
 
Antiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeriesAntiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeries
Hiralal Pawar
 

What's hot (20)

Early reperfusion in myocardial infarction
Early reperfusion in myocardial infarctionEarly reperfusion in myocardial infarction
Early reperfusion in myocardial infarction
 
Nuclear cardiology
Nuclear cardiologyNuclear cardiology
Nuclear cardiology
 
Anaesthesia for orthopaedic replacement surgeries
Anaesthesia for orthopaedic replacement surgeriesAnaesthesia for orthopaedic replacement surgeries
Anaesthesia for orthopaedic replacement surgeries
 
Seizures post cardiac surgery
Seizures post cardiac surgerySeizures post cardiac surgery
Seizures post cardiac surgery
 
Myocardial viability
Myocardial viabilityMyocardial viability
Myocardial viability
 
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
Effect of Intracoronary Application of Nicorandil and Tirofiban on No-Reflow ...
 
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
No reflow Phenomenon Dr Hafeesh Fazulu - Pushpagiri - Jan 2021
 
Management of no reflow
Management of no reflowManagement of no reflow
Management of no reflow
 
A case of prosthetic mitral valve with
A case of prosthetic mitral valve  withA case of prosthetic mitral valve  with
A case of prosthetic mitral valve with
 
STEMI – My Approach 2010
STEMI – My Approach 2010STEMI – My Approach 2010
STEMI – My Approach 2010
 
Poster 33 biochimie
Poster 33 biochimiePoster 33 biochimie
Poster 33 biochimie
 
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, AlternativesAnesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
Anesthesia for Carotid Endarterectomy: Risks, Benefits, Alternatives
 
Perioperative management of antithrombotic therapy
Perioperative management of antithrombotic therapyPerioperative management of antithrombotic therapy
Perioperative management of antithrombotic therapy
 
Percutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarctionPercutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarction
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRI
 
Acs(stemi nstemi ua
Acs(stemi nstemi ua Acs(stemi nstemi ua
Acs(stemi nstemi ua
 
Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (Neuroanesthesiology at hospital universitario central de asturias (
Neuroanesthesiology at hospital universitario central de asturias (
 
Anesthesia in patients on anti coagulants
Anesthesia in patients on anti coagulantsAnesthesia in patients on anti coagulants
Anesthesia in patients on anti coagulants
 
high blood pressure 19
high blood pressure 19high blood pressure 19
high blood pressure 19
 
Antiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeriesAntiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeries
 

Similar to Nuclear cardiology dated info

Nuclear cardiology
Nuclear cardiologyNuclear cardiology
Nuclear cardiology
Frank Meissner
 
Cardiac diagnostics
Cardiac diagnosticsCardiac diagnostics
Cardiac diagnostics
MitchellChapman5
 
Nuclear Radiology.pptx
Nuclear Radiology.pptxNuclear Radiology.pptx
Nuclear Radiology.pptx
ssusere208d4
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
GOPAL GHOSH
 
Anaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgeryAnaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgery
Dhritiman Chakrabarti
 
0319report
0319report0319report
0319report
Shen-Chih Wang
 
Anesthesia for laparoscopic and robotic surgeries [autosaved]
Anesthesia for laparoscopic and robotic surgeries [autosaved]Anesthesia for laparoscopic and robotic surgeries [autosaved]
Anesthesia for laparoscopic and robotic surgeries [autosaved]
bitoysbasics
 
Viability assessment final new
Viability assessment final newViability assessment final new
nuclear urology.pptx
nuclear urology.pptxnuclear urology.pptx
nuclear urology.pptx
Islah Raoof
 
Tcd seminar GMC kota
Tcd seminar GMC kotaTcd seminar GMC kota
Tcd seminar GMC kota
NeurologyKota
 
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
Euro CTO Club
 
Endarterectomy
EndarterectomyEndarterectomy
Endarterectomy
Anuj Mehta
 
Nuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeonsNuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeons
SrikanthK120
 
TCD seminar vaibhav.pptx
TCD seminar vaibhav.pptxTCD seminar vaibhav.pptx
TCD seminar vaibhav.pptx
NeurologyKota
 
Anaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgeryAnaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgery
Dhritiman Chakrabarti
 
Anesthetic Consideration in neuro interventional procedure.pptx
Anesthetic Consideration in neuro interventional procedure.pptxAnesthetic Consideration in neuro interventional procedure.pptx
Anesthetic Consideration in neuro interventional procedure.pptx
BABAR SURI
 
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptxEffect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
NayyarSaleem2
 
San jose 2011
San jose 2011San jose 2011
San jose 2011
Marcelo Langleib
 
Sonothrombolysis in acute stroke
Sonothrombolysis in acute strokeSonothrombolysis in acute stroke
Sonothrombolysis in acute stroke
NeurologyKota
 
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
info622939
 

Similar to Nuclear cardiology dated info (20)

Nuclear cardiology
Nuclear cardiologyNuclear cardiology
Nuclear cardiology
 
Cardiac diagnostics
Cardiac diagnosticsCardiac diagnostics
Cardiac diagnostics
 
Nuclear Radiology.pptx
Nuclear Radiology.pptxNuclear Radiology.pptx
Nuclear Radiology.pptx
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Anaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgeryAnaesthesia for robotic cardiac surgery
Anaesthesia for robotic cardiac surgery
 
0319report
0319report0319report
0319report
 
Anesthesia for laparoscopic and robotic surgeries [autosaved]
Anesthesia for laparoscopic and robotic surgeries [autosaved]Anesthesia for laparoscopic and robotic surgeries [autosaved]
Anesthesia for laparoscopic and robotic surgeries [autosaved]
 
Viability assessment final new
Viability assessment final newViability assessment final new
Viability assessment final new
 
nuclear urology.pptx
nuclear urology.pptxnuclear urology.pptx
nuclear urology.pptx
 
Tcd seminar GMC kota
Tcd seminar GMC kotaTcd seminar GMC kota
Tcd seminar GMC kota
 
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
Saturday 0930 – Werner - Complication Management in PCI for Chronic Total Cor...
 
Endarterectomy
EndarterectomyEndarterectomy
Endarterectomy
 
Nuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeonsNuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeons
 
TCD seminar vaibhav.pptx
TCD seminar vaibhav.pptxTCD seminar vaibhav.pptx
TCD seminar vaibhav.pptx
 
Anaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgeryAnaesthesia for functional neurosurgery
Anaesthesia for functional neurosurgery
 
Anesthetic Consideration in neuro interventional procedure.pptx
Anesthetic Consideration in neuro interventional procedure.pptxAnesthetic Consideration in neuro interventional procedure.pptx
Anesthetic Consideration in neuro interventional procedure.pptx
 
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptxEffect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
 
San jose 2011
San jose 2011San jose 2011
San jose 2011
 
Sonothrombolysis in acute stroke
Sonothrombolysis in acute strokeSonothrombolysis in acute stroke
Sonothrombolysis in acute stroke
 
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
Anaesthetic Management of a Case of Dilated Cardiomyopathy for Breast Surgery...
 

More from Frank Meissner

BigDataInMedicine.pptx
BigDataInMedicine.pptxBigDataInMedicine.pptx
BigDataInMedicine.pptx
Frank Meissner
 
Eating D/O
Eating D/OEating D/O
Eating D/O
Frank Meissner
 
Bipolar D/O
Bipolar D/O Bipolar D/O
Bipolar D/O
Frank Meissner
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
Frank Meissner
 
PE case
PE casePE case
Pediatric delirium
Pediatric deliriumPediatric delirium
Pediatric delirium
Frank Meissner
 
Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018
Frank Meissner
 
Drug induced brugadda apa
Drug induced brugadda apaDrug induced brugadda apa
Drug induced brugadda apa
Frank Meissner
 
Curanderos presentation
Curanderos presentation Curanderos presentation
Curanderos presentation
Frank Meissner
 
Pills & Thrills
Pills & ThrillsPills & Thrills
Pills & Thrills
Frank Meissner
 
Verona sleep hx presentation
Verona sleep hx presentationVerona sleep hx presentation
Verona sleep hx presentation
Frank Meissner
 
Burns zagreb presentation
Burns zagreb presentationBurns zagreb presentation
Burns zagreb presentation
Frank Meissner
 
Hemmorhagic fever zagreb
Hemmorhagic fever zagrebHemmorhagic fever zagreb
Hemmorhagic fever zagreb
Frank Meissner
 
Tropical cardiology
Tropical cardiologyTropical cardiology
Tropical cardiology
Frank Meissner
 
Schistomasis
SchistomasisSchistomasis
Schistomasis
Frank Meissner
 
Onchocerciasis
OnchocerciasisOnchocerciasis
Onchocerciasis
Frank Meissner
 
Malaria
MalariaMalaria
Visceral leishmanasis
Visceral leishmanasisVisceral leishmanasis
Visceral leishmanasis
Frank Meissner
 
Chest pain perals
Chest pain peralsChest pain perals
Chest pain perals
Frank Meissner
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Frank Meissner
 

More from Frank Meissner (20)

BigDataInMedicine.pptx
BigDataInMedicine.pptxBigDataInMedicine.pptx
BigDataInMedicine.pptx
 
Eating D/O
Eating D/OEating D/O
Eating D/O
 
Bipolar D/O
Bipolar D/O Bipolar D/O
Bipolar D/O
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
 
PE case
PE casePE case
PE case
 
Pediatric delirium
Pediatric deliriumPediatric delirium
Pediatric delirium
 
Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018
 
Drug induced brugadda apa
Drug induced brugadda apaDrug induced brugadda apa
Drug induced brugadda apa
 
Curanderos presentation
Curanderos presentation Curanderos presentation
Curanderos presentation
 
Pills & Thrills
Pills & ThrillsPills & Thrills
Pills & Thrills
 
Verona sleep hx presentation
Verona sleep hx presentationVerona sleep hx presentation
Verona sleep hx presentation
 
Burns zagreb presentation
Burns zagreb presentationBurns zagreb presentation
Burns zagreb presentation
 
Hemmorhagic fever zagreb
Hemmorhagic fever zagrebHemmorhagic fever zagreb
Hemmorhagic fever zagreb
 
Tropical cardiology
Tropical cardiologyTropical cardiology
Tropical cardiology
 
Schistomasis
SchistomasisSchistomasis
Schistomasis
 
Onchocerciasis
OnchocerciasisOnchocerciasis
Onchocerciasis
 
Malaria
MalariaMalaria
Malaria
 
Visceral leishmanasis
Visceral leishmanasisVisceral leishmanasis
Visceral leishmanasis
 
Chest pain perals
Chest pain peralsChest pain perals
Chest pain perals
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 

Nuclear cardiology dated info

  • 1. Nuclear Cardiology Frank Meissner, MD, FACP, FACC, FACP Chief of Cardiology
  • 2. General Appoach ●IV administration of radiolabeled agents ●Scintillation or positron camera ●Computer processing ●Physiologic/functional data, rather than structural/anatomic ●e.g., Myocardial perfusion imaging is prognostically more important than classification by angiography
  • 3. Types of Studies/Agents ●Myocardial Perfusion Thallium-201 (201Tl), technetium-99m sestamibi ●Blood Pool/First Pass Tc 99m pertechnetate ●Myocardial Infarct ●PET
  • 4. Myocardial Perfusion -Thallium 201 imaging ●Intracellular transport by passive and active mechanisms ●Early myocardial uptake directly proportional to regional myocardial blood flow and myocardial extraction fraction
  • 5. Myocardial Perfusion -Thallium 201 imaging ●After initial phase continuous exchange of myocardial 201Tl and extracardiac 201Tl ●This process of continuous exchange is the basis of 201Tl redistribution ●Thallium, metallic element group IIIA - periodic table
  • 6. Thallium Redistribution ●Defined as total or partial resolution of initial postexercise defects ●Reimaging at 2.5 to 4 hrs after tracer injection ●Late reimaging is performed when defects are believed to be due to severe ischemia
  • 7. Technical Considerations ●2.5 to 3.0 mCi of 201Tl via IV cannula ●End-points: angina , dyspnea, fatigue, claudication, hypotension ●Exercise 30 to 45 s so that initial myocardial uptake reflects peak exercise ●Image within 5 minutes post exercise
  • 8. Thallium TMT interpretation ●Decreased 201Tl uptake ischemia or scar ●Reversible defects = ischemia ●30% of persistent defects = severe ischemia rather than scar ●Reinjection protocols reveals reversibility in 40% of 4 hr ‘defects’ ●24 hr redistribution imaging show reversibility in 20-25% of ‘fixed’ 4
  • 9. Sensitivity/Specificity Considerations ●Qualitative visual 201Tl using planar imaging sensitivity and sensitivity of 84 & 87% respectively ●Quantatively analysis (computer assistance) 90% sensitivity & specificity ●Spect 201 Tl increased sensitivity with decreased specificity
  • 10. SPECT ADVANTAGES ●Images free of background ●Lesion contrast higher ●Localization of defects is more precise and more clearly seen by the inexperienced eye ●Extent and size of defects better defined
  • 11. Sensitivity Factors ●Left circumflex lesions difficult to ID ●Branch stenoses of arteries more difficult ●Sensitivity for single vessel disease << sensitivity for multivessel disease ●Less sensitive suboptimal exercise ●Not influcenced by antianginal drugs ●NOT a good test post-CABG
  • 12. HIGH RISK Characteristics ●Multiple 201 Tl defects in multiple vascular regions ●Increased Lung uptake (defined by lung/heart ratio > .5) ●Exercise induced transient LV dilatation
  • 13. PROGNOSTIC Characteristics ●Presence of reversible defects worse prognosis than fixed defects ●Total number of defects best prognositic indicator vs Presence of Lung uptake (reported as POORER prognosis than total segments) ●Chest Pain + TOTALLY normal 201Tl scans < 1% yrly risk of sudden death
  • 14. Resting Thallium ●Useful technique for case selection in patients with depressed LVEF & CAD ●‘Hibernating’ myocardium preserved 201Tl uptake at rest ●IV 201Tl imaged at 20 mins and 4 hours ●Resting hypoperfusion will demonstrate initial defects that fill with redistribution ●Asynergy with preserved 201Tl uptake improved systolic function post-Bypass
  • 15. 201Tl Limitations ●Breast tissue attenuates tracer penetration ●Large RV blood pool overlying inferior wall on Anterior Projection => artifact ●High left Hemidiaphragm overlying post wall ●SPECT imaging relatively less than 201Tl activity in the inferobasilar segments on short axis images
  • 16. 99mTc sestamibi Imaging I ●Lipophilic cationic 99mTc-complex whose myocardial uptake proportional to blood flow ●140 keV photon energy peak is optimized for gamma camera imaging ●Produces higher quality images than those produced by 201Tl
  • 17. 99mTc sestamibi Imaging II ●Shorter half life than 201Tl permits administration of 10-15 X’s as high a dose of tracer than 201Tl ●Gated acquisition of SPECT allows for animation and rgn wall motion analysis ●First PASS acquisition can yield LVEF at rest or exercise with animation for MUGA like scans done prior to
  • 18. 99mTc-sestamibi Technical Characteristics ●Does NOT redistribute after injection ●Separate injections during stress and resting states ●Ideal protocol is 24 hours between rest and stress ●However, current practice is to inject and image rest followed by Stress images ●Increased photon energy defeats attenuation & artifacts
  • 19. Sensitivity & Specificity ●Sensitivity is reported at 85-90% range ●Increased specificity with superior image quality and decreased image artifacts ●Some authors report more individually stenosed arteries are dected by sestabmibi SPECT than
  • 20. Pharmacologic Stress Imaging ●Useful for patients UNABLE to exercise to reasonable double products ●Adenosine vs dipyridamole protocols ●Critical coronary stenosis detected by reduced flow reserve in stenotic area ●Degree of vasodilatation is less relative to increase in flow in normal segments ●Sensitivity and specificity is comparable to that reported with exercise protocols
  • 21. Dipyridamole Stress Imaging: Cavets/Technique ●NO caffeinated beverages for 12 hrs prior to the test ●NO use of Theophylline compounds ●0.56 mg/kg dipyridamole infused over 4 minutes ●3.0 mCi 201Tl injected at 9 minutes, with intial images at 5 mins post injection ●Aminophylline (50-100 mg IV) for systemic hypertension, chest pain, severe nausea
  • 22. Adenosine Stress Imaging: Technique ●IV adenosine 140ug/kg/min for 6 minutes ●3 mins after starting infusion inject with 3.0 mCi dose of 201Tl in contralateral vein ●Additional 3 minute infusion of adenosine
  • 23. USEFULNESS of Pharmacological stress testing ●Predominately for PreOp eval of vascular surgical patient ●Preoperative 201Tl defects experience a 7X > periorperative ischemic event rate ●PATIENTS WITH RECURRENT ANGINA AT REST should NOT receive pharmacological stress
  • 24. Radionuclide angiography ●Blood pool imaging rather than myocardial avid tracers ●Information obtained is identical to that of contrast ventriculography ●In vivo labeling with 99mTc ●IV stannous pyrophosphate is injected 15-20 mins prior to 15-30 mCi of 99mTc
  • 25. Uses I ●Differentiation of ischemic from nonischemic cardiomyopathy ●Cancer patient monitoring for doxorubicin by serial estimate of EF ●RV fxn and size with first pass for suspected RV infarction ●RV dynamics in COPD
  • 26. Uses II ●Bicycle ergometry for detection of CAD ●Timing of valve replacement in regurgitant valvular disease - serial studies ●Post MI risk stratification
  • 27. First Pass Imaging ●Single bolus of 99mTc is injected rapidly via IV (preferably central line) ●Analysis is limited to intial transit Multicrystal scintillation camera prefered to single-crystal Anger Camera, since high count ●Rates (up to 400,000 counts/sec) can be obtained with multiple crystal cameras
  • 28. Equilibration Imaging I ●Multiple Gated Acquisition Scan (MUGA) ●Equal subdivisions of the patients cardiac cycle ●Generally 30-50ms framing interval at rest or 20-30 ms for exercise study ●200 successive cardiac cycles, with R-wave gating
  • 29. Equilibration Imaging II ●Several algorithms and methods to deal with R-R wave variability ●DO NOT SEND A Fib or Bigemy/Trigemeny patient to MUGA ●Time Activity Curve - Relative volume curve ●Displayed with activity in LV vs time ●Change in activity is proportional to change in LV volume
  • 30. Data Obtained ●LVEF ●RVEF ●Peak systolic ejection rate ●Regurgitant fraction ●Diastolic filling time ●Left to right intracardiac shunts ●Phase analysis
  • 31. MUGA Advantages ●Highly reproducible EF ●Able to image patients NOT well seen with Echo ●NO geometric assumptions are made in the calculation of EF (MOST IMPORTANT ADVANTAGE) ●Wall motion analysis is VERY comparable to ECHO & LV-gram
  • 32. Myocardial infarction imaging ●Radiopharmaceutical is preferentially sequestered in necrotic myocardial tissue ●Yields a hot spot on the scan ●99mTc pyrophosphate first agent used ●Scan is abnormal 12-24 hours after MI ●Recent interest in indium-111(111In) antimyosin antibodies
  • 33. Technique ●Fab fragments of antimyosin antibodies labeled with 111In ●Images obtained one hour after injection
  • 34. Clinical Uses ●NOT useful for routine patients ●Late patients (>2 days from Chest pain with negative enzymes and equivocal EKG’s) ●Surgical MI’s, i.e., patient felt to have MI in OR ●Acute Myocarditis ●Acute and chronic allograft rejection
  • 35. PET ●Positron emission tomography ●Imaged with short half life positron emitors such as carbon-11 (11C), nitrogen-13 (13N), oxygen-15 (15O), fluorine-18 (18F), and rubidium-82 (82Rb) ●Generator produced half lifes of 75 seconds to 2 minutes
  • 36. Uses ●Research TOOL ONLY ●For testing purposes the hallmark of Myocardial Viability in ‘stunned’ or hibernating myocardium is increased FDG (18F, 2-fluoro-2-deoxyglucose) activity in myocardial tissue ●Diminished perfusion with increased FDG activity is due to glycolysis ●Diminished perfusion with diminished FDG activity implies NO viability